Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 71 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8426425

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  2. US 8426359

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  3. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    UNIVERSITY OF CONNECTICUT · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  4. US 8426458

    Hepatitis C Virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  5. US 8420596

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  6. US 8420852

    Phospholipase A2 inhibitors and their use in treating neurological injury and disease

    The Regents of the University of California · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  7. US 8420650

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  8. US 8420816

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  9. US 8420678

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  10. US 8410112

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  11. US 8410133

    Aminopyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  12. US 8404852

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  13. US 8399666

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  14. US 8399478

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  15. US 8399458

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  16. US 8399425

    Alleviating neuropathic pain with EETs and sEH inhibitors

    The Regents of the University of California · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  17. US 8394788

    Phenylsulfoxyoxazole compound inhibitors of urea transporters

    The Regents of the University of California · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  18. US 8394951

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  19. US 8394952

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  20. US 8394803

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  21. US 8389731

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Northwestern University · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  22. US 8389734

    Amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  23. US 8389557

    Triazole derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  24. US 8383583

    Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted